[HTML][HTML] A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
JF Rossignol, MC Bardin, J Fulgencio… - …, 2022 - thelancet.com
Background There is an urgent need for treatments of mild or moderate COVID-19 in an
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19.
JF Rossignol, MC Bardin, J Fulgencio, D Mogelnicki… - 2022 - cabidigitallibrary.org
Background: There is an urgent need for treatments of mild or moderate COVID-19 in an
outpatient setting. Methods: A randomized double-blind placebo-controlled clinical trial in 36 …
outpatient setting. Methods: A randomized double-blind placebo-controlled clinical trial in 36 …
[HTML][HTML] A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
JF Rossignol, MC Bardin, J Fulgencio… - …, 2022 - ncbi.nlm.nih.gov
Background There is an urgent need for treatments of mild or moderate COVID-19 in an
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
JF Rossignol, MC Bardin, J Fulgencio… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background There is an urgent need for treatments of mild or moderate COVID-19 in an
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
[HTML][HTML] A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
JF Rossignol, MC Bardin, J Fulgencio, D Mogelnicki… - eClinicalMedicine, 2022 - Elsevier
Background There is an urgent need for treatments of mild or moderate COVID-19 in an
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19.
JF Rossignol, MC Bardin, J Fulgencio… - …, 2022 - europepmc.org
Background There is an urgent need for treatments of mild or moderate COVID-19 in an
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …